| Product NDC: | 0228-2571 |
| Proprietary Name: | Indapamide |
| Non Proprietary Name: | Indapamide |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Indapamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0228-2571 |
| Labeler Name: | Actavis Elizabeth LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074722 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070102 |
| Package NDC: | 0228-2571-11 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0228-2571-11) |
| NDC Code | 0228-2571-11 |
| Proprietary Name | Indapamide |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0228-2571-11) |
| Product NDC | 0228-2571 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Indapamide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070102 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Elizabeth LLC |
| Substance Name | INDAPAMIDE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |